Johnson & Johnson (JNJ) Revenue & Revenue Breakdown
Johnson & Johnson Revenue Highlights
Latest Revenue (Y)
$85.15B
Latest Revenue (Q)
$22.45B
Main Segment (Y)
MedTech
Main Geography (Y)
UNITED STATES
Johnson & Johnson Revenue by Period
Johnson & Johnson Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $85.15B | -10.31% |
| 2023-01-01 | $94.94B | 1.25% |
| 2022-01-02 | $93.78B | 13.55% |
| 2021-01-03 | $82.58B | 0.64% |
| 2019-12-29 | $82.06B | 0.59% |
| 2018-12-30 | $81.58B | 6.71% |
| 2017-12-31 | $76.45B | 6.34% |
| 2017-01-01 | $71.89B | 2.59% |
| 2016-01-03 | $70.07B | -5.73% |
| 2014-12-28 | $74.33B | 4.23% |
| 2013-12-29 | $71.31B | 6.08% |
| 2012-12-30 | $67.22B | 3.37% |
| 2012-01-01 | $65.03B | 5.59% |
| 2011-01-02 | $61.59B | -0.50% |
| 2010-01-03 | $61.90B | -2.90% |
| 2008-12-28 | $63.75B | 4.34% |
| 2007-12-30 | $61.09B | 14.57% |
| 2006-12-31 | $53.32B | 5.56% |
| 2006-01-01 | $50.51B | 6.69% |
| 2005-01-02 | $47.35B | 13.10% |
| 2003-12-28 | $41.86B | 15.33% |
| 2002-12-29 | $36.30B | 9.98% |
| 2001-12-30 | $33.00B | 13.26% |
| 2000-12-31 | $29.14B | 6.07% |
| 2000-01-02 | $27.47B | 16.12% |
| 1999-01-03 | $23.66B | 4.54% |
| 1997-12-28 | $22.63B | 4.67% |
| 1996-12-31 | $21.62B | 14.74% |
| 1995-12-31 | $18.84B | 19.75% |
| 1995-01-01 | $15.73B | 11.29% |
| 1994-01-02 | $14.14B | - |
Johnson & Johnson generated $85.15B in revenue during NA 2023, up -10.31% compared to the previous quarter, and up 104.38% compared to the same period a year ago.
Johnson & Johnson Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $22.45B | 4.98% |
| 2024-03-31 | $21.38B | -0.04% |
| 2023-12-31 | $21.39B | 0.22% |
| 2023-10-01 | $21.34B | -16.44% |
| 2023-07-02 | $25.55B | 3.28% |
| 2023-04-02 | $24.73B | 4.34% |
| 2023-01-01 | $23.71B | -0.36% |
| 2022-10-02 | $23.79B | -0.95% |
| 2022-07-03 | $24.02B | 2.54% |
| 2022-04-03 | $23.43B | -5.56% |
| 2022-01-02 | $24.80B | 6.28% |
| 2021-10-03 | $23.34B | 0.11% |
| 2021-07-04 | $23.31B | 4.44% |
| 2021-04-04 | $22.32B | -0.69% |
| 2021-01-03 | $22.48B | 6.61% |
| 2020-09-27 | $21.08B | 14.98% |
| 2020-06-28 | $18.34B | -11.38% |
| 2020-03-29 | $20.69B | -0.27% |
| 2019-12-29 | $20.75B | 0.09% |
| 2019-09-29 | $20.73B | 0.81% |
| 2019-06-30 | $20.56B | 2.70% |
| 2019-03-31 | $20.02B | -1.83% |
| 2018-12-30 | $20.39B | 0.23% |
| 2018-09-30 | $20.35B | -2.31% |
| 2018-07-01 | $20.83B | 4.10% |
| 2018-04-01 | $20.01B | -0.92% |
| 2017-12-31 | $20.20B | 2.77% |
| 2017-10-01 | $19.65B | 4.30% |
| 2017-07-02 | $18.84B | 6.04% |
| 2017-04-02 | $17.77B | -1.88% |
| 2017-01-01 | $18.11B | 1.60% |
| 2016-10-02 | $17.82B | -3.58% |
| 2016-07-03 | $18.48B | 5.72% |
| 2016-04-03 | $17.48B | -1.85% |
| 2016-01-03 | $17.81B | 4.15% |
| 2015-09-27 | $17.10B | -3.85% |
| 2015-06-28 | $17.79B | 2.38% |
| 2015-03-29 | $17.37B | -4.82% |
| 2014-12-28 | $18.25B | -1.15% |
| 2014-09-28 | $18.47B | -5.27% |
| 2014-06-29 | $19.50B | 7.62% |
| 2014-03-30 | $18.11B | -1.31% |
| 2013-12-29 | $18.36B | 4.44% |
| 2013-09-29 | $17.57B | -1.69% |
| 2013-06-30 | $17.88B | 2.13% |
| 2013-03-31 | $17.50B | -0.30% |
| 2012-12-30 | $17.56B | 2.97% |
| 2012-09-30 | $17.05B | 3.50% |
| 2012-07-01 | $16.48B | 2.08% |
| 2012-04-01 | $16.14B | -0.71% |
| 2012-01-01 | $16.25B | 1.56% |
| 2011-10-02 | $16.00B | -3.57% |
| 2011-07-03 | $16.60B | 2.62% |
| 2011-04-03 | $16.17B | 3.38% |
| 2011-01-02 | $15.64B | 4.42% |
| 2010-10-03 | $14.98B | -2.27% |
| 2010-07-04 | $15.33B | -1.93% |
| 2010-04-04 | $15.63B | -5.56% |
| 2010-01-03 | $16.55B | 9.75% |
| 2009-09-27 | $15.08B | -1.04% |
| 2009-06-28 | $15.24B | 1.42% |
| 2009-03-29 | $15.03B | -1.03% |
| 2008-12-28 | $15.18B | -4.64% |
| 2008-09-28 | $15.92B | -3.22% |
| 2008-06-29 | $16.45B | 1.58% |
| 2008-03-30 | $16.19B | 1.49% |
| 2007-12-30 | $15.96B | - |
Johnson & Johnson generated $22.45B in revenue during Q2 2024, up 4.98% compared to the previous quarter, and up 90.75% compared to the same period a year ago.
Johnson & Johnson Revenue Breakdown
Johnson & Johnson Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Jan 23 | Jan 22 | Jan 21 | Dec 19 |
|---|---|---|---|---|---|
| MedTech | $30.40B | $27.43B | - | - | - |
| Pharmaceutical | - | $52.56B | - | - | - |
| Consumer | - | $14.95B | $14.63B | $14.05B | $13.90B |
Johnson & Johnson's latest annual revenue breakdown by segment (product or service), as of Dec 23: MedTech (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedTech | $7.96B | $7.82B | $7.67B | $7.46B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Medical Devices | - | - | - | - | $7.79B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pharmaceutical | - | - | - | - | $13.73B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Consumer | - | - | - | - | $4.01B | $3.85B | $3.77B | $3.79B | $3.81B | $3.59B | $3.66B | $3.70B | $3.73B | $3.54B | $3.62B | $3.51B | $3.30B | $3.63B | $3.57B | $3.47B |
Johnson & Johnson's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: MedTech (100.00%).
Johnson & Johnson Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Jan 23 | Jan 22 | Jan 21 | Dec 19 |
|---|---|---|---|---|---|
| Asia-Pacific, Africa | $13.76B | $16.79B | $17.27B | $15.14B | $15.55B |
| Western Hemisphere, excluding U.S. | $4.55B | $6.13B | - | - | - |
| UNITED STATES | $46.44B | $48.58B | $47.16B | $43.13B | $42.10B |
| Europe | $20.41B | $23.45B | $23.59B | $18.98B | $18.47B |
Johnson & Johnson's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (54.54%), Europe (23.97%), Asia-Pacific, Africa (16.15%), and Western Hemisphere, excluding U.S. (5.34%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Oct 23 | Jul 23 | Apr 23 | Oct 22 | Jul 22 | Apr 22 | Oct 21 | Jul 21 | Apr 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jul 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Western Hemisphere, excluding U.S. | $1.21B | $1.19B | $1.17B | $1.71B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asia-Pacific, Africa | $3.45B | $3.41B | $3.46B | $4.48B | $4.31B | $4.25B | $4.20B | $4.51B | $4.29B | $4.36B | $4.37B | $3.88B | $3.60B | $3.66B | $3.99B | $3.97B | $3.78B | $3.72B | $3.84B | - |
| Europe | $5.21B | $5.16B | $4.73B | $5.89B | $6.33B | $5.52B | $6.08B | $6.02B | $5.59B | $5.67B | $5.41B | $4.82B | $4.06B | $4.83B | $4.46B | $4.73B | $4.61B | $4.42B | $4.81B | - |
| Non-US | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.06B | - | - |
| UNITED STATES | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.48B | - | - |
Johnson & Johnson's latest quarterly revenue breakdown by geography, as of Jun 24: Europe (52.78%), Asia-Pacific, Africa (34.95%), and Western Hemisphere, excluding U.S. (12.27%).
Johnson & Johnson Peer Comparison by Revenue
JNJ Revenue FAQ
What is Johnson & Johnson’s yearly revenue?
Johnson & Johnson's yearly revenue for 2023 was $85.15B, representing a decrease of -10.31% compared to 2022. The company's yearly revenue for 2022 was $94.94B, representing an increase of 1.25% compared to 2021. JNJ's yearly revenue for 2021 was $93.78B, representing an increase of 13.55% compared to 2020.
What is Johnson & Johnson’s quarterly revenue?
Johnson & Johnson's quarterly revenue for Q2 2024 was $22.45B, a 4.98% increase from the previous quarter (Q1 2024), and a -12.13% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $21.38B, a -0.04% decrease from the previous quarter (Q4 2023), and a -13.55% decrease year-over-year (Q1 2023). JNJ's quarterly revenue for Q4 2023 was $21.39B, a 0.22% increase from the previous quarter (Q3 2023), and a -9.77% decrease year-over-year (Q4 2022).
What is Johnson & Johnson’s revenue growth rate?
Johnson & Johnson's revenue growth rate for the last 3 years (2021-2023) was -9.20%, and for the last 5 years (2019-2023) was 3.77%.
What are Johnson & Johnson’s revenue streams?
Johnson & Johnson's revenue streams in c 23 are MedTech
What is Johnson & Johnson’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Johnson & Johnson was MedTech. This segment made a revenue of $30.4B, representing 100.00% of the company's total revenue.